Buy, Sell or Hold: Piramal Pharma Ltd, Kaynes Technology India Ltd, Electronics Mart — Ask Profit

Experts advise investors to wait for Q3 earnings before buying Kaynes Technology shares.

Advertisement
Read Time: 2 mins
NDTV Profit's Ask Profit show.
Photo: Created by Microsoft Copilot

Should you hold shares of Piramal Pharma? Should you add shares of Kaynes Technology India Ltd. at the current market price? Have you lost the chance to buy shares of Hitachi Energy at an attractive price? Is it the right time to exit Electronics Mart?

Kush Bohra from Kush Bohra.com and Prashanth Tapse, senior vice president at Mehta Equities, provided insights on these investor queries and more on NDTV Profit's Ask Profit show.

Advertisement

Kaynes Tech (CMP: 3527.70)

Prashanth: Wait and Watch

  • Q3 Earnings will give a very clear picture.
  • From last two quarters, earnings have been deteriorating.
  • First leg of automation can be done.

Out of 26 analysts tracking the company, 14 maintain a 'buy' rating, eight recommend a 'hold,' and four suggest 'sell,' according to Bloomberg data. The average 12-month consensus price target of Rs 5573.52 implies an upside of 58.1%.

Electronics Mart (CMP: 87.58)

Kush: Start exiting gradually to par loss

  • Stocks seeing massive downfall.
  • Volumes on the downside.
  • Stock close to oversold directories.

Piramal Pharma (CMP: 157.66)

Prashanth: Hold

  • Forsee CDMO section doing well.
  • Earnings expected to do well.
  • Decent upside on the current levels.

Out of four analysts tracking the company, three maintain a 'buy' rating, one recommend a 'hold,' and none suggest 'sell,' according to Bloomberg data. The average 12-month consensus price target of Rs 1727.50 implies a downside of 5.8%.

Advertisement

Hitachi Energy

Kush: Hold

  • Don't average out right now.
  • Stock consolidated with mild positive buy.
  • Good support zone for positional stock.

Out of 13 analysts tracking the company, nine maintain a 'buy' rating, one recommend a 'hold,' and three suggest 'sell,' according to Bloomberg data. The average 12-month consensus price target of Rs 22,697 implies an upside of 34.5%.

Disclaimer: The views and opinions expressed by the investment advisers on NDTV Profit are of their own and not of NDTV Profit. NDTV Profit advises users to consult with their own financial or investment adviser before taking any investment decision. 

Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit.

Loading...